Arrowhead Added to NASDAQ Biotechnology Index®
The NASDAQ Biotechnology Index is designed to track the performance of a
set of securities listed on The NASDAQ Stock Market® that are classified
as either biotechnology or pharmaceutical according to the Industry
Classification Benchmark. The NASDAQ Biotechnology Index is calculated
under a modified capitalization-weighted methodology and ranked on an
annual basis. All securities in the NASDAQ Biotechnology Index are
listed on the
For more information about the NASDAQ Biotechnology Index, including eligibility criteria, visit www.nasdaq.com.
About
For more information please visit http://www.arrowheadresearch.com, or follow us on Twitter @ArrowRes. To be added to the Company's email list and receive news directly, please visit http://ir.arrowheadresearch.com/alerts.cfm.
Safe Harbor Statement under the Private Securities Litigation Reform Act:
This news release contains forward-looking statements within the
meaning of the "safe harbor" provisions of the Private Securities
Litigation Reform Act of 1995. These statements are based upon our
current expectations and speak only as of the date hereof. Our actual
results may differ materially and adversely from those expressed in any
forward-looking statements as a result of various factors and
uncertainties, including our ability to finance our operations, the
future success of our scientific studies, our ability to successfully
develop drug candidates, the timing for starting and completing clinical
trials, rapid technological change in our markets, and the enforcement
of our intellectual property rights.
DYNAMIC POLYCONJUGATES is a trademark of
View source version on businesswire.com: http://www.businesswire.com/news/home/20151214006139/en/
626-304-3400
ir@arrowres.com
or
Investor
Relations:
646-378-2926
ir@arrowres.com
or
Media:
Matt Middleman, M.D.
212-845-4272
matt.middleman@russopartnersllc.com
Source:
News Provided by Acquire Media